125 related articles for article (PubMed ID: 2140973)
1. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Cipolli C; Chiari G
Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
[TBL] [Abstract][Full Text] [Related]
2. L-acetylcarnitine treatment of mental decline in the elderly.
Salvioli G; Neri M
Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
[TBL] [Abstract][Full Text] [Related]
3. [Methodology of a clinical controlled study of L-acetylcarnitine].
Neri M; Cortelloni C; De Vreese L
Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
[TBL] [Abstract][Full Text] [Related]
5. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
[TBL] [Abstract][Full Text] [Related]
6. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
[TBL] [Abstract][Full Text] [Related]
8. Methodology of a controlled clinical study for cerebral aging evaluation.
Vecchi GP; Neri M; Cortelloni C; De Vreese L; Sirotti C; Cipolli C; Fabbri L; Zerbini O
Int J Clin Pharmacol Res; 1990; 10(1-2):145-52. PubMed ID: 2201654
[TBL] [Abstract][Full Text] [Related]
9. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
12. [Methodological premises of statistical analysis of the data].
Bamfi F; Girelli M
Clin Ter; 1990 Mar; 132(6 Suppl):475-8. PubMed ID: 2140972
[TBL] [Abstract][Full Text] [Related]
13. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
Genazzani E
Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974
[No Abstract] [Full Text] [Related]
14. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
Bella R; Biondi R; Raffaele R; Pennisi G
Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
[TBL] [Abstract][Full Text] [Related]
15. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
Arrigo A; Casale R; Buonocore M; Ciano C
Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
[TBL] [Abstract][Full Text] [Related]
16. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
Herrmann WM; Dietrich B; Hiersemenzel R
Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
[TBL] [Abstract][Full Text] [Related]
17. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Bonavita E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
[TBL] [Abstract][Full Text] [Related]
18. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
[TBL] [Abstract][Full Text] [Related]
19. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Garzya G; Corallo D; Fiore A; Lecciso G; Petrelli G; Zotti C
Drugs Exp Clin Res; 1990; 16(2):101-6. PubMed ID: 2205455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
